Evidence map›Paper›PMID 27527800›Full record

ArticleNature communications2016

Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens.

Erin W Meermeier, Bruno F Laugel, Andrew K Sewell, Alexandra J Corbett, Jamie Rossjohn, James McCluskey, Melanie J Harriff, Tamera Franks, Marielle C Gold, David M Lewinsohn

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 122 citations in OpenAlex.

  1. Select intratumoral riboflavin-auxotrophicProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. T cells in Group AFrontiers in cellular and infection microbiology · 2026
    Review
  8. Sorting endosomes play key roles in presentation ofbioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. MR1 presents vitamin B6-related compounds for recognition by MR1-reactive T cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Erin W MeermeierDepartment of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon 97239 USA.
Bruno F LaugelInstitute of Infection and Immunity, Henry Wellcome Research Institute, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.
Andrew K SewellInstitute of Infection and Immunity, Henry Wellcome Research Institute, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.
Alexandra J CorbettDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria 3010, Australia.
Jamie RossjohnInstitute of Infection and Immunity, Henry Wellcome Research Institute, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.
James McCluskeyDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria 3010, Australia.
Melanie J HarriffDepartment of Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, Oregon 97239, USA.
Tamera FranksDepartment of Research, VA Portland Health Care Center, Portland, Oregon 97239, USA.
Marielle C GoldDepartment of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon 97239 USA.ORCID 0000-0003-2505-3291
David M LewinsohnDepartment of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon 97239 USA.
Oregon Health & Science University · USInstitute of Infection and Immunity · CAThe University of Melbourne · AUARC Centre of Excellence in Advanced Molecular Imaging · AUVA Portland Health Care System · US

Funding

Human MAIT celis in airway mucosal immune responses to intracellular infectionsU01AI095776 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M. · 2011 to 2015
$8.9M
INTERACTIONS AT THE MICROBE/HOST INTERFACET32AI007472 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LANDFEAR, SCOTT M · 1995 to 2019
$6.7M
Multidisciplinary Research Training in Pulmonary MedicineT32HL083808 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M., SLATORE, CHRISTOPHER G. · 2008 to 2025
$5.3M
Recognition of Mtb-infected Cells by CD8+ T LymphocytesR01AI048090 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M. · 2001 to 2016
$4.2M
Inflammation and T Lymphocyte ImmunoregulationT32AI078903 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI HILL, ANN B · 2009 to 2013
$1.5M
Mechanisms of recognition by Mycobacterium tuberculosis-reactive thymocytesR01AI078965 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI GOLD, MARIELLE C. · 2010 to 2013
$1.1M
Recognition of Mtb-Infected Cells by Non-Classically Restritcted CD8+ T CellsI01BX000533 · VA · PORTLAND VA MEDICAL CENTER · PI LEWINSOHN, DAVID M. · 2011 to 2024
–
Mtb uptake and antigen presentation in human lung epithelial cellsIK2CX000538 · VA · PORTLAND VA MEDICAL CENTER · PI HARRIFF, MELANIE J · 2012 to 2016
–
Innate Immune Effectors in Early Immune Response to Mycobacterium TuberculosisI01BX001231 · VA · PORTLAND VA MEDICAL CENTER · PI GOLD, MARIELLE C. · 2012 to 2015
–
BLRD VA I01 BX000533BLRD VA I01 BX001231CSRD VA IK2 CX000538NHLBI NIH HHS T32 HL083808NIAID NIH HHS R01 AI048090NIAID NIH HHS R01 AI078965NIAID NIH HHS T32 AI007472NIAID NIH HHS T32 AI078903NIAID NIH HHS U01 AI095776
6 · The paper itself

Abstract

Mucosal-associated invariant T (MAIT) cells are thought to detect microbial antigens presented by the HLA-Ib molecule MR1 through the exclusive use of a TRAV1-2-containing TCRα. Here we use MR1 tetramer staining and ex vivo analysis with mycobacteria-infected MR1-deficient cells to demonstrate the presence of functional human MR1-restricted T cells that lack TRAV1-2. We characterize an MR1-restricted clone that expresses the TRAV12-2 TCRα, which lacks residues previously shown to be critical for MR1-antigen recognition. In contrast to TRAV1-2(+) MAIT cells, this TRAV12-2-expressing clone displays a distinct pattern of microbial recognition by detecting infection with the riboflavin auxotroph Streptococcus pyogenes. As known MAIT antigens are derived from riboflavin metabolites, this suggests that TRAV12-2(+) clone recognizes unique antigens. Thus, MR1-restricted T cells can discriminate between microbes in a TCR-dependent manner. We postulate that additional MR1-restricted T-cell subsets may play a unique role in defence against infection by broadening the recognition of microbial metabolites.

Indexed as

A549 CellsAntigen PresentationAntigensCell LineCells, CulturedHistocompatibility Antigens Class IHost-Pathogen InteractionsHumansMinor Histocompatibility AntigensMucosal-Associated Invariant T CellsReceptors, Antigen, T-Cell, alpha-betaRiboflavinStreptococcal InfectionsStreptococcus pyogenesT-Lymphocyte SubsetsAntigensHistocompatibility Antigens Class IMinor Histocompatibility AntigensMR1 protein, humanReceptors, Antigen, T-Cell, alpha-betaRiboflavin

Identifiers

PMID27527800
PMCPMC4990709
OpenAlexW2513049377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.